Roche, Chiasma ink deal on hormone disorder treatment (Reuters, 18 February 2013)

Drugmakers Roche and Chiasma have announced plans to work together to develop and market an oral formulation of octreotide for patients with acromegaly. Full article
Source: Society for Endocrinology - Category: Endocrinology Source Type: news